Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1975 May 1;141(5):1181–1200. doi: 10.1084/jem.141.5.1181

Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens

PMCID: PMC2189780  PMID: 47896

Abstract

Experiments were designed to explore the apparent paradox that methylcholanthrene-induced tumors of mice evoke tumor-unique transplantation immunity but reveal almost complete cross-reacting antigenicity in tests of lymphocyte behavior in vitro. The approach involved use of tumor membranes solubilized in 3 M KCl, employed both as the stimulating antigen source in a new in vitro proliferation assay of lymphocyte recognition, and as immunogens in vivo. The kinetics of the assay resembled those of in vitro tests of mitogen or specific antigen stimulation in other systems. Lymphoid cell proliferation was assessed in peripheral blood leukocytes, lymph nodes (LN), and spleen over the course of tumor bearing, and in animals immunized by tumor amputation or with the solubilized antigens. The pattern of spread of reactivity was from regional LN to spleen, peripheral blood, and nonregional nodes in each circumstance. An unexplained low antigen dose inhibitory phenomenon was encountered in spontaneously proliferating cell subpopulations taken from some tumor-bearing animals. In vitro responses to some but not all solubilized antigens made from multiple syngeneic tumors were detected in each circumstance. The soluble antigens also induced shared resistance to some tumors. The patterns of spread of responsiveness to syngeneic tumor antigens, the time-course, and relative intensity were most compatible with independent clonal responses to multiple tumor-borne antigens, some but not all of which are shared in any family of syngeneic tumors.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R. J., McBride C. M., Hersh E. M. In vitro lymphocyte responses to malignant, benign neoplastic and normal tissue extracts. Proc Soc Exp Biol Med. 1972 Jun;140(2):465–470. doi: 10.3181/00379727-140-36481. [DOI] [PubMed] [Google Scholar]
  2. Ankerst J., Steele G., Jr, Sjögren H. O. Cross-reacting tumor-associated antigen(s) of adenovirus type 9-induced fibroadenomas and a chemically induced mammary carcinoma in rats. Cancer Res. 1974 Aug;34(8):1794–1800. [PubMed] [Google Scholar]
  3. Baldwin R. W., Embleton M. J. Neoantigens on spontaneous and carcinogen-induced rat tumors defined by in vitro lymphocytotoxicity assays. Int J Cancer. 1974 Apr 15;13(4):433–443. doi: 10.1002/ijc.2910130402. [DOI] [PubMed] [Google Scholar]
  4. Baldwin R. W., Embleton M. J., Price M. R. Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions. Int J Cancer. 1973 Jul 15;12(1):84–92. doi: 10.1002/ijc.2910120109. [DOI] [PubMed] [Google Scholar]
  5. Baldwin R. W., Glaves D., Vose B. M. Embryonic antigen expression in chemically induced rat hepatomas and sarcomas. Int J Cancer. 1972 Sep 15;10(2):233–243. doi: 10.1002/ijc.2910100202. [DOI] [PubMed] [Google Scholar]
  6. Baldwin R. W., Price M. R., Robins R. A. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes. Nat New Biol. 1972 Aug 9;238(84):185–186. doi: 10.1038/newbio238185a0. [DOI] [PubMed] [Google Scholar]
  7. Baldwin R. W., Price M. R., Robins R. A. Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen. Int J Cancer. 1973 May;11(3):527–535. doi: 10.1002/ijc.2910110304. [DOI] [PubMed] [Google Scholar]
  8. Bartlett G. L. Effect of host immunity on the antigenic strength of primary tumors. J Natl Cancer Inst. 1972 Aug;49(2):493–504. [PubMed] [Google Scholar]
  9. Coggin J. H., Jr, Ambrose K. R., Bellomy B. B., Anderson N. G. Tumor immunity in hamsters immunized with fetal tissues. J Immunol. 1971 Aug;107(2):526–533. [PubMed] [Google Scholar]
  10. David J. R. Mediators produced by sensitized lymphocytes. Fed Proc. 1971 Nov-Dec;30(6):1730–1735. [PubMed] [Google Scholar]
  11. Dickinson J. P., McDermott J. R., Smith J. K., Caspary E. A. A common tumour specific antigen. II. Further characterization of the whole antigen and of a cross-reacting antigen of normal tissues. Br J Cancer. 1974 Jun;29(6):425–432. doi: 10.1038/bjc.1974.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. FOLEY E. J. Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res. 1953 Dec;13(12):835–837. [PubMed] [Google Scholar]
  13. Fujimoto S., Chen C. H., Sabbadini E., Sehon A. H. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice. J Immunol. 1973 Oct;111(4):1093–1100. [PubMed] [Google Scholar]
  14. Gebhardt B. M., Nakao Y., Smith R. T. Clonal character of F1 hybrid lymphocyte subset recognition of parental cells in one-way mixed lymphocyte cultures. J Exp Med. 1974 Aug 1;140(2):370–382. doi: 10.1084/jem.140.2.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gutterman J. U., Hersh E. M., Mavligit G. M., Freireich E. J., Rossen R. D., Butler W. T., McCredie K. B., Bodey G. P., Sr, Rodriguez V. Cell-mediated and humoral immune response to acute leukemia cells and soluble leukemia antigen--relationship to immunocompetence and prognosis. Natl Cancer Inst Monogr. 1973 Jun;37:153–165. [PubMed] [Google Scholar]
  16. Gutterman J. U., Mavligit G., McCredie K. B., Bodey G. P., Sr, Freireich E. J., Hersh E. M. Antigen solubilized from human leukemia: lymphocyte stimulation. Science. 1972 Sep 22;177(4054):1114–1115. doi: 10.1126/science.177.4054.1114. [DOI] [PubMed] [Google Scholar]
  17. Halliday W. J. Blocking effect of serum from tumor-bearing animals on macrophage migration inhibition with tumor antigens. J Immunol. 1971 Mar;106(3):855–857. [PubMed] [Google Scholar]
  18. Halliday W. J. Macrophage migration inhibition with mouse tumor antigens: properties of serum and peritoneal cells during tumor growth and after tumor loss. Cell Immunol. 1972 Jan;3(1):113–122. doi: 10.1016/0008-8749(72)90231-6. [DOI] [PubMed] [Google Scholar]
  19. Hellström I., Hellström K. E. Cell-bound immunity to autologous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs. Science. 1967 May 19;156(3777):981–983. doi: 10.1126/science.156.3777.981. [DOI] [PubMed] [Google Scholar]
  20. Hellström I., Hellström K. E., Sjögren H. O., Warner G. A. Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer. 1971 Jan 15;7(1):1–16. doi: 10.1002/ijc.2910070102. [DOI] [PubMed] [Google Scholar]
  21. Hellström K. E., Hellström I. Immunological enhancement as studied by cell culture techniques. Annu Rev Microbiol. 1970;24:373–398. doi: 10.1146/annurev.mi.24.100170.002105. [DOI] [PubMed] [Google Scholar]
  22. Hirschberg H., Thorsby E. Specificity of responding cell populations in mixed lymphocyte cultures. Cell Immunol. 1973 Jul;8(1):173–176. doi: 10.1016/0008-8749(73)90105-6. [DOI] [PubMed] [Google Scholar]
  23. Kearney R., Nelson D. S. Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity. Aust J Exp Biol Med Sci. 1973 Dec;51(6):723–735. doi: 10.1038/icb.1973.70. [DOI] [PubMed] [Google Scholar]
  24. Konda S., Nakao Y., Smith R. T. Immunologic properties of mouse thymus cells. Identification of T cell functions within a minor, low-density subpopulation. J Exp Med. 1972 Dec 1;136(6):1461–1477. doi: 10.1084/jem.136.6.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Konda S., Nakao Y., Smith R. T. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen. Cancer Res. 1973 Oct;33(10):2247–2256. [PubMed] [Google Scholar]
  26. Konda S., Smith R. T. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations. Cancer Res. 1973 Aug;33(8):1878–1884. [PubMed] [Google Scholar]
  27. Leonard E. J., Meltzer M. S., Borsos T., Rapp H. J. Properties of tumor-specific antigen solubilized by hypertonic potassium chloride. Natl Cancer Inst Monogr. 1972 Dec;35:129–134. [PubMed] [Google Scholar]
  28. Lieber M. M., Sherr C. J., Todaro G. J. S-tropic murine type-C viruses: frequency of isolation from continuous cell lines, leukemia virus preparations and normal spleens. Int J Cancer. 1974 May 15;13(5):587–598. doi: 10.1002/ijc.2910130503. [DOI] [PubMed] [Google Scholar]
  29. Littman B. H., Meltzer M. S., Cleveland R. P., Zbar B., Rapp H. J. Tumor-specific, cell-mediated immunity in guinea pigs with tumors. J Natl Cancer Inst. 1973 Nov;51(5):1627–1635. doi: 10.1093/jnci/51.5.1627. [DOI] [PubMed] [Google Scholar]
  30. Mavligit G. M., Gutterman J. U., McBride C. M., Hersh E. M. Cell-mediated immunity to human solid tumors: in vitro detection by lymphocyte blastogenic responses to cell-associated and solubilized tumor antigens. Natl Cancer Inst Monogr. 1973 Jun;37:167–176. [PubMed] [Google Scholar]
  31. Meltzer M. S., Leonard E. J., Rapp H. J., Borsos T. Tumor-specific antigen solubilized by hypertonic potassium chloride. J Natl Cancer Inst. 1971 Sep;47(3):703–709. [PubMed] [Google Scholar]
  32. Meltzer M. S., Oppenheim J. J., Littman B. H., Leonard E. J., Rapp H. J. Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens. J Natl Cancer Inst. 1972 Sep;49(3):727–734. [PubMed] [Google Scholar]
  33. Ménard S., Colnaghi M. I., Della Porta G. In vitro demonstration of tumor-specific common antigens and embryonal antigens in murine fibrosarcomas induced by 7,12-dimethylbenz(a)anthracene. Cancer Res. 1973 Mar;33(3):478–481. [PubMed] [Google Scholar]
  34. PREHN R. T., MAIN J. M. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst. 1957 Jun;18(6):769–778. [PubMed] [Google Scholar]
  35. Pellis N. R., Tom B. H., Kahan B. D. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas. J Immunol. 1974 Aug;113(2):708–711. [PubMed] [Google Scholar]
  36. Poon S. P., Cauchi M. N. Blastogenic response of lymphoid cells to tumor cells or tumor membrane extracts in vitro. Cancer Res. 1973 Nov;33(11):2677–2682. [PubMed] [Google Scholar]
  37. Prager M. D., Hollinshead A. C., Ribble R. J., Derr I. Induction of immunity to a mouse lymphoma by multiple methods, including vaccination with soluble membrane fractions. J Natl Cancer Inst. 1973 Nov;51(5):1603–1607. doi: 10.1093/jnci/51.5.1603. [DOI] [PubMed] [Google Scholar]
  38. Reisfeld R. A., Pellegrino M. A., Kahan B. D. Salt extraction of soluble HL-A antigens. Science. 1971 Jun 11;172(3988):1134–1136. doi: 10.1126/science.172.3988.1134. [DOI] [PubMed] [Google Scholar]
  39. Salmon S. E., Krakauer R. S., Whitmore W. F. Lymphocyte stimulation: selective destruction of cells during blastogenic response to transplantation antigens. Science. 1971 Apr 30;172(3982):490–492. doi: 10.1126/science.172.3982.490. [DOI] [PubMed] [Google Scholar]
  40. Szakal A. K., Hanna M. G., Jr Cell-mediated immune response of hamsters to alloantigen and tumor antigens of isologous and autochthonous origin during chemical carcinogenesis. Cancer Res. 1974 Jan;34(1):138–145. [PubMed] [Google Scholar]
  41. Takasugi M., Klein E. A microassay for cell-mediated immunity. Transplantation. 1970 Mar;9(3):219–227. doi: 10.1097/00007890-197003000-00005. [DOI] [PubMed] [Google Scholar]
  42. Ting C. C., Lavrin D. H., Shiu G., Herberman R. B. Expression of fetal antigens in tumor cells. Proc Natl Acad Sci U S A. 1972 Jul;69(7):1664–1668. doi: 10.1073/pnas.69.7.1664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Vánky R., Klein E., Stjernswärd J., Nilsonne U. Cellular immunity against tumor-associated antigens in humans: lymphocyte stimulation and skin reaction. Int J Cancer. 1974 Aug 15;14(2):277–288. doi: 10.1002/ijc.2910140217. [DOI] [PubMed] [Google Scholar]
  44. Yoshiki T., Mellors R. C., Hardy W. D., Jr, Fleissner E. Common cell surface antigen associated with mammalian C-type RNA viruses. Cell membrane-bound gs antigen. J Exp Med. 1974 Apr 1;139(4):925–942. doi: 10.1084/jem.139.4.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Zoschke D. C., Bach F. H. In vitro elimination of specific immunoreactive cells with 5-bromodeoxyuridine. J Immunol Methods. 1971 Sep;1(1):55–65. doi: 10.1016/0022-1759(71)90005-6. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES